Denileukin diftitox (Ontak)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Denileukin diftitox (Ontak), covering 2013-05-30 to 2013-07-02. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer [Phase 2]